CBLL Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: The Motley Fool

CeriBell (CBLL) Q3 2025 Earnings Call Transcript

11 days ago - By: Ceribell

Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

13 days ago - By: Zacks Investment Research - Mentions: CAPR

CeriBell, Inc. (CBLL) Reports Q3 Loss, Beats Revenue Estimates

13 days ago - By: Ceribell

Ceribell Reports Third Quarter 2025 Financial Results

13 days ago - By: Ceribell

Ceribell Reports Third Quarter 2025 Financial Results

13 days ago - By: Benzinga - Mentions: KURA SEE HRMY FOLD ...

Earnings Scheduled For November 4, 2025

3 months ago - By: Benzinga - Mentions: AFG CXDO YUM PACK ...

Earnings Scheduled For August 5, 2025

19 days ago - By: Zacks Investment Research - Mentions: EOLS

Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know

a month ago - By: Ceribell

Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025

a month ago - By: Ceribell

Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025

2 months ago - By: Ceribell

Medtech Leader Erica Rogers Joins Ceribell Board of Directors

2 months ago - By: Ceribell

Medtech Leader Erica Rogers Joins Ceribell Board of Directors

3 months ago - By: Yahoo Finance - Mentions: JPM

J.P. Morgan Maintains a Buy Rating on CeriBell (CBLL) With a $21 PT

3 months ago - By: The Motley Fool

CeriBell (CBLL) Q2 Revenue Jumps 38%

3 months ago - By: Ceribell

Ceribell Reports Second Quarter 2025 Financial Results

3 months ago - By: Ceribell

Ceribell Reports Second Quarter 2025 Financial Results

4 months ago - By: Ceribell

Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference

4 months ago - By: Ceribell

Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference

4 months ago - By: Ceribell

Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025

4 months ago - By: Ceribell

Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware

4 months ago - By: Ceribell

Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware

6 months ago - By: Yahoo Finance - Mentions: BBNX BA HWM CRWV ...

The medtech IPO window is finally open. Or is it?

6 months ago - By: Ceribell

Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference

6 months ago - By: Ceribell

Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference

6 months ago - By: Ceribell

Ceribell Reports First Quarter 2025 Financial Results

7 months ago - By: Ceribell

Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference

7 months ago - By: Ceribell

Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference

7 months ago - By: Ceribell

Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems

7 months ago - By: Ceribell

Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025

7 months ago - By: Ceribell

Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025

7 months ago - By: Ceribell

FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older

7 months ago - By: Stocktwits

CERIBELL INC (CBLL) Stock News

CBLL Latest News, Press Relases and Analysis

CeriBell (CBLL) Q3 2025 Earnings Call Transcript

Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

CeriBell, Inc. (CBLL) Reports Q3 Loss, Beats Revenue Estimates

Ceribell Reports Third Quarter 2025 Financial Results

Ceribell Reports Third Quarter 2025 Financial Results

Earnings Scheduled For November 4, 2025

Earnings Scheduled For August 5, 2025

Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know

Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025

Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025

Medtech Leader Erica Rogers Joins Ceribell Board of Directors

Medtech Leader Erica Rogers Joins Ceribell Board of Directors

J.P. Morgan Maintains a Buy Rating on CeriBell (CBLL) With a $21 PT

CeriBell (CBLL) Q2 Revenue Jumps 38%

Ceribell Reports Second Quarter 2025 Financial Results

Ceribell Reports Second Quarter 2025 Financial Results

Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference

Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference

Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025

Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware

Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware

The medtech IPO window is finally open. Or is it?

Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference

Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference

Ceribell Reports First Quarter 2025 Financial Results

Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference

Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference

Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems

Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025

Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025

FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older

Ceribell's Retail Popularity Surges After Small-Cap Medtech Firm Assures No Tariff Impact Until Q4